Positive news: The bottling of the Covid-19 vaccine from Sinovac by Pharmaniaga is expected to begin soon.
PETALING JAYA: Pharmaniaga Bhd
’s earnings forecast for the financial year 2020 and 2021 remains unchanged, pending further disclosure from the management on the earnings impact resulting from the fill-and-finish agreement, said MIDF Research.
The research house also reiterated its earlier view that the potential upside from the fill-and-finish as well as vaccine distribution will more or less be rather minimal on the company’s earnings.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
